2 news items
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
IDYA
4 Mar 24
at 8:00 AM ET • Panel: "Novel Targeted-Oncology
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
IDYA
20 Feb 24
: 8 patients have been dosed in the IDE397 monotherapy expansion in the priority tumor types, and 2 patients have not yet had a first tumor scan
- Prev
- 1
- Next